Day: October 22, 2021

MENLO PARK, Calif. and SINGAPORE, Oct. 22, 2021 (GLOBE NEWSWIRE) — ASLAN Pharmaceuticals (Nasdaq: ASLN), a clinical-stage, immunology-focused biopharmaceutical company developing innovative treatments to transform the lives of patients, today announced a collaboration with renowned inflammatory skin disease expert Dr Emma Guttman-Yassky, MD PhD, to conduct research that will continue throughout ASLAN’s Phase 2b program to identify and characterize the effects of ASLAN004 on disease-associated skin and serum-biomarkers in adults with moderate-to-severe atopic dermatitis (AD). Dr Guttman-Yassky is Chair of the Department of Dermatology at the Icahn School of Medicine at Mount Sinai and a world leader on inflammatory skin diseases. Her research has led to significant breakthroughs in the understanding of the immunologic basis of AD,...

DENVER, Oct. 22, 2021 (GLOBE NEWSWIRE) — The Simply Good Foods Company (Nasdaq: SMPL) (“Simply Good Foods,” or the “Company”), a developer, marketer and seller of branded nutritional foods and snacking products, today reported financial results for the thirteen and fifty-two weeks ended August 28, 2021. The Company’s fiscal fourth quarter 2021 and full year results include Quest results for the full period. The Company’s fiscal fourth quarter 2020 results include thirteen weeks of Quest and about forty-two weeks for the prior year. Fourth Quarter Highlights:(1)Net sales increased 16.9% driven by solid Atkins and Quest performance Gross profit margin of 40.2%, an increase of 60 basis points Net income(2) of $18.2 million versus a net loss(2) of $39.3 million Earnings per diluted share(2) of $0.19 versus a loss per diluted share...

SHANGHAI, China, Oct. 22, 2021 (GLOBE NEWSWIRE) — Genetron Holdings Limited (“Genetron Health” or the “Company”, NASDAQ: GTH), a leading precision oncology platform company in China that specializes in molecular profiling tests, early cancer screening products and companion diagnostics development, today announced that it has entered into an exclusive agreement with Jiangsu Fosun Pharmaceutical Sales Co., Ltd (“Jiangsu Fosun Pharma”), a subsidiary of Shanghai Fosun Pharmaceutical (Group) Co., Ltd. (“Fosun Pharma”, Stock code: 600196.SH, 02196.HK), to commercialize Seq-MRD®, a molecular diagnostic assay for the detection of minimal residual disease (MRD) in patients suffering from select hematologic cancers. The partnership marks the launch of Genetron Health’s first product for hematologic cancer and MRD detection in the China...

ROBIT PLC          INSIDE INFORMATION          22 OCTOBER 2021 AT 2.00 P.M.            ROBIT PLC UPDATES ITS FINANCIAL GUIDANCE FOR 2021 Robit Plc updates its earlier financial guidance for 2021 based on improved visibility on business outlook for the company’s second half of the year. New guidance Robit Plc expects the market situation to remain on a good level in the end of the year. The company estimates that net sales for 2021 will grow and comparable EBITDA profitability in euros will improve as follows: net sales being between EUR 97.0–101.0 million and comparable EBITDA profitability being at least EUR 7.0 million, assuming that exchange rates remain on the level of September 2021. Previous guidance Robit Plc expects the market situation to develop positively and believes COVID-19 restrictions to have a limited impact on the demand...

SUNNYVALE, Calif., Oct. 22, 2021 (GLOBE NEWSWIRE) — eGain Corporation (NASDAQ: EGAN), a leading cloud platform provider for customer engagement automation, today announced that a Top 5 insurance company in the US has selected eGain Knowledge Hub™ as its strategic knowledge management platform for customer service and member engagement. Hit by pandemic refunds for auto insurance and payouts from natural disasters such as hurricanes, floods and wildfires, insurance leaders are investing in digital transformation to improve customer experience and reduce cost. As part of the program, they want to empower contact center reps and field agents with contextual, proactive knowledge, while complying with industry regulations. Hamstrung by their legacy knowledge system, the carrier launched an extensive RFP process to modernize its knowledge...

Bonum Bank PlcStock Exchange Release22 October 2021, at 13.15 Bonum Bank Plc applies for the listing of its notes on the official list of Nasdaq Helsinki Ltd Bonum Bank Plc issues EUR 20 million senior and unsecured notes under the Bonum Bank Plc EUR 750,000,000 Programme for the Issuance of Notes. The notes have floating interest rate and are maturing 20 October 2026. The final terms of the notes are available in English on the company’s website at https://www.poppankki.fi/en/pop-pankki-ryhma/bonum-bank-plc/investor-relations. The ISIN code of the notes is FI4000512785. Bonum Bank Plc has filed today an application for the admission of the notes to trading on the official list of Nasdaq Helsinki Ltd.   Additional information: Pia Ali-Tolppa, CEO, Bonum Bank Plc, tel. +358 50 303 1476, pia.ali-tolppa@poppankki.fi Timo Hulkko, director,...